Maxim initiated coverage of Autonomix (AMIX) with a Buy rating and $5 price target
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AMIX:
- Autonomix granted new European Patent for catheter-based technology
- Autonomix engages advisors to guide clinical, regulatory path in cancer pain
- Autonomix granted U.S. patent for catheter-based technology
- Autonomix advances toward U.S. clinical trials in 2025
- Autonomix files $200M mixed securities shelf